There are a lot of AI coding applications out there, and as impressive as large language models and the agents they enable have become, many of the most recent developments in AI-assisted development have been in the software that manages those models, not just the models themselves.

Earlier this summer, I spoke with the head of product for Claude Code, Anthropic's Cat Wu, about that company's approach to building that software.

Read full article

Comments

Anti-vaccine Health Secretary Robert F. Kennedy Jr. has stacked another federal advisory panel with allies, advancing his efforts to force the Food and Drug Administration to reverse its stance on a dozen popular but unproven injectable peptide drugs.

While FDA scientists determined in 2023 that the drugs lack evidence of benefits and may pose safety risks, Kennedy is a self-professed "big fan" of the dubious drugs and has vowed to "end" FDA's "aggressive suppression" of them.

On Monday, the Food and Drug Administration updated its list of advisors who will review the peptides, adding nine new members—almost all of whom personally promote peptide use and/or have financial ties to wellness clinics that offer peptide treatments. The additions bring the total number of advisors to 13, making it easy for the new members to determine the outcome of upcoming meetings.

Read full article

Comments